In the dormant state, tumour cells persist under growth restraint for long periods. Tumour dormancy has been explained as the prolonged arrest of cells in the G. phase of the mitotic cycle (Gelfant, 1977) . However, observations in animal models have shown that the cells of dormant tumours continue to divide with reduced frequency (Vaage & Pepin, 1985) . The dormant state is inherently unstable and the mechanisms involved are complex. Hormonal (Noble & Hoover, 1975) , nutritional (vascular) (Brem et al., 1976; Weinhold et al., 1979) , and host resistance factors (Eccles & Alexander, 1975) , are known to be involved in the restraint of tumour growth. Tumour factors such as phenotypic diversity (Weinhold et al., 1979) , tumour invasive factors (e.g. collagenase) (Woolley, 1982; Pauli et al., 1983) , antigen shedding (Davey et al., 1976) , and immunosuppressive factors (Eccles & Alexander, 1975) , may be involved when growth resumes.
The mammary carcinoma MC2, which with predictable frequencies becomes dormant and/or regresses in normal mice and in suboptimally immunised mice, is a suitable model to study host reactions that restrain tumour growth. It seems likely that tumour encapsulation may be at least partially responsible for tumour dormancy and slow regression, because every dormant and regressing MC2 implant examined histologically was enclosed in a cellular-fibrous capsule. A connection between tumour fibrosis and tumour regression has also been noted by Benjamin et al. (1977) and by Key and Haskill (1981) .
Because collagen deposition may be an important inhibitor of tumour expansion, and because of the significance of growth restraint (dormancy) in the natural control of cancer, it is important to clarify the cellular aspects of tumour encapsulation. Large numbers of T lymphocytes and macrophages were always seen to be closely associated with all stages of the process of MC2 encapsulation (Vaage & Pepin, 1985) , inviting speculation that the macrophages might be involved in the collagen formation. Because of the longstanding uncertainly about the origin and identity of the productive cells in fibrotic conditions (Dumont, 1974; Boros, 1978; Rennard et al., 1984) , and because mouse peritoneal macrophages have recently been shown to produce as much type I collagen as mouse tail fibroblasts in direct in vitro comparisons (Vaage & Lindblad, 1990) , the purpose of this investigation was to study tumour encapsulation during the primary immune response, and to determine whether the T lymphocyte may influence the collagen forming capacity of the macrophage. This would be a step toward understanding some of the circumstances of pathologic fibrosis, as in, e.g. tumour encapsulation.
Materials and methods

Mice
The mice used in these experiments were 8 to 10 week-old female C3H/He mice, raised and kept in a filtered-air environment.
Tumour
The mammary carcinoma MC2 developed spontaneously in a multiparous C3H/He mouse and has been transplanted in syngeneic female mice. The second transplant generation is stored in liquid N2, and the tumour was used here in the third to seventh transplant generations. This immunogenic tumour has the characteristic of being rejected, after reaching a size of as much as 10 mm (average 6.5 T-lymphocyte isolation Inguinal, axillary, and brachial lymph nodes from 10-weekold C3H/He mice or thymuses from 3-week-old C3H/He mice, were teased apart in phosphate buffered saline (PBS) with 10% foetal calf serum (FCS) . The single cells in the suspension were flushed through a 12 ml nylon wool column using 25 ml PBS added 1 drop per s. The eluted cells were spun down, resuspended in RPMI-1640 medium with 10% FCS and incubated on plastic for 1 h to remove remaining adherent cells. The proportion of T cells in the final suspension was determined by immunoperoxidase staining with monoclonal antibody (MAb) against Thy 1.2, Lyt 1, with Lyt 2 markers.
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Immunoperoxidase staining Tumours to be examined for macrophage and collagen type I distribution were sectioned in a cryostat, at 7 rim, directly after being excised. The sections were fixed in cold acetone for 5 min and air dried. The staining followed the procedure described by Taylor (1978 in PBS, to the outside of both sides of the chambers. The 0.4 pm pores admit the collagen produced by the peritoneal cells into the chamber, the 0.05 jm pores do not. Thus, by making the chambers from two different membranes, it could be determined whether the collagen was produced by the peritoneal cells outside the chambers, in which case the collagen fibres would be seen on the inside of the 0.4 ptm membrane only, or produced by cells placed in the chambers, and collagen seen on the inside of both membranes. The two sides of the chambers were held together by a ring of doublesticky Scotch tape with a 5 mm hole. The chambers were trimmed to an outside diameter of 9 mm with a 5 mm 'neck' to provide a good seal for the channel through which the chambers were filled with medium or with a cell suspension. A 40 mm length of Intramedic tube PElO (Clay Adams, Parsippany, NJ) was placed in the neck when the chambers were made, and a 3 mm piece of the tubing was placed in the chamber to keep the membranes separated. The chambers were gas-sterilised with Anprolene (H.W. Anderson Prods. Inc., Oyster Bay, NY). After a chamber was filled with medium or cell suspension, the 40 mm tube was pulled out and the chamber sealed. The chambers were implanted i.p. through a mid-ventral incision with the mice under Penthrane anaesthesia. The abdominal wall incisions were closed with silk sutures, the skin incisions with wound clips.
Collagenase treatment of Nuclepore chambers Freshly removed chambers were washed in PBS with magnetic stirring for 1 h. Chambers were then cut in half. One half was placed in a 5 ml centrifuge tube with 1.5 ml PBS, the second half in 1.5 ml PBS with 500 units of chromatographically purified bacterial collagenase Type IV (Worthington, Freehold, NJ) and shaken for 2 h at 37°C. The chambers were rinsed in PBS for 30 min and prepared for scanning electron microscopy (SEM).
Electron microscopy For SEM, Nuclepore chambers removed from the peritoneum were placed directly in PBS with magnetic stirring for 1 h. The chambers were fixed in 3% gluteraldehyde for 24 h and dehydrated in cold 50; 70; 80; 90; and 95% ethanol. The capsules were opened and twice dehydrated in absolute ethanol for 15 min. The membranes were then treated with liquid CO2 in a critical point drying chamber (Bomar SPC-50). The membranes were mounted on sample stubs with conducting graphite paint as adhesive and gold coated with a sputter coater (Polaron SEM coating unit E5100). The specimens were examined in an ETEC Autoscan at 20 kV.
For transmission electron microscopy (TEM), dehydrated and critical-point-dried membranes were angle-shadowed with platinum-carbon and vertically coated with carbon. The specimen-replica were released from the specimen by 0.1 N hydrochloric acid flotation, followed by 50% Chlorox flotation to clean, and lastly, floated on distilled water to rinse. The replica were mounted on colloidon-coated copper grids and examined in a Siemens IOIA electron microscope.
Results
Capsule formation Every dormant or regressing MC2 implant removed for histological examination was found to be surrounded by a cellular-fibrous capsule. By the location of resorcin-crystal violet, injected via the left ventricle, it was found that such tumours were also invariably without active vascular supply, even when the surrounding stroma was highly vascular. The apparent effect of the encapsulation was to occlude the vascular supply to the tumour, possibly by the suggested mechanism of collagen fibre shrinkage (Benjamin et al., 1977) . Progressively growing tumours, expanding into the surrounding stroma, were well vascularised. The fibrous encapsulation of non-expanding irradiated (3,000 r) control tumour implants showed that the reaction was true encapsulation and not compressed stromal tissue (pseudocapsule). Figure 2 shows a detail of the capsule formation around a 6 mm tumour that had been dormant for 2 weeks after 3 weeks of growth. Figure 3 shows a detail from a cryostat section from the same tumour stained with Mac-I immunoperoxidase for macrophage identification. It can be seen that the more recently extravasated round mononuclear cells and most of the spindle-shaped mononuclear cells closer to the tumour were equally stained. Figure 4 shows a detail from the same area of the tumour as shown in Figure 3 , stained with anti collagen type I immunoperoxidase. The staining of cytoplasmic procollagen is dense in several of the cells. These cells, by their similarity in number and peritumour location compared to the stained cells in Figure 3 , may be assumed to also be macrophages. Collagen formation into i.p. Nuclepore membrane chambers Evidence of the ability of peritoneal macrophages to form collagen in culture has been reported (Vaage & Lindbald, 1990 or Lyt-2, (fibroblasts) were not found in the peritoneal fluid. The proportion of macrophages increased in the peritoneal fluid during the 18 to 72 h sampling period. SEM examination of chambers containing 103 eluted nylon wool adherent lymph node cells found that a thin, loose mesh of fibres had formed on the inner surfaces of both the 0.05 jtm and the 0.4 gm pore-size membranes already 18 h after i.p. implantation. This was a control that showed that a mixed cell population that probably contained both macrophages and fibroblasts, produced collagen inside the chambers. Chambers containing cultre medium or 103 P3 myeloma cells, had a thin layer of fibres formed only on the inside of the 0.4 ym membrane after 72 h i.p. (Figure 5 ). Chambers containing 103 lymph node T cells or thymocytes, had a multi-layered net of fibres only on the inside of the 0.4 Am, membrane after 48 h i.p. (Figure 6 ). TEM examination of the fibres showed the 67 nm banding characteristic of collagen. The fibres were dissolved after incubation in collagenase for 2 h. Table I summarises the results of this study. Table 1 . The perspective of the SEM makes the T lymphocytes on the left appear larger than the true scale. Bar = 1 jLm. Figure 6 ). T-cells were also always seen in close association with macrophages during the tumour encapsulation process.
The role of T-cells may be to direct and to enhance collagen synthesis in certain pathologic conditions. It has already been demonstrated that unspecified lymphocyte products (Johnson & Ziff, 1976; Postlethwaite et al., 1984) , unspecified T-cell products (Wahl & Gately, 1983) , interleukin-l, which is produced by many cells including T-cells (Goldring & Krane, 1987; Postlethwaite et al., 1988) , and transforming growth factor beta, produced by T-cells and macrophages (Roberts et al., 1986; Raghow et al., 1987) , influence collagen production by cultured fibroblasts. The depletion of T-cells inhibited the formation of bacterial cell wall-induced hepatic granulomas in vivo (Wahl et al., 1986) , and reduced the ability of immune spleen cells to form granulomas around Schistosoma eggs in vitro (Bentley et al., 1982) . The enhanced collagen fibre formation seen in the Nuclepore chambers that contained T-cells is therefore in agreement with observations in other experimental systems.
Procollagen is secreted (exocytosed) as 325 nm-long units, and collagen fibril formation follows spontaneously upon enzymatic removal of the propeptide end pieces (Kivirikko & Mylylla, 1984) . It is likely therefore, that the 325 nm procollagen units and the procollagen N-terminal and C-terminal proteases pass through the 400 nm wide and 10,000 nm long pores of the 0.4,im membrane before fibril formation inside the chamber. The pores of the 0.05 jim membranes are 50 nm wide and 6,000 nm long, which is apparently too narrow for the passage of the procollagen molecules. The formation of collagen fibres inside Nuclepore chambers via the pores is in line with the observations of Pauli that the process of collagen fibres formation does not require the close presence of the collagen-producing cells, but with proceed spontaneously in solutions of collagen monomers (Pauli et al., 1983) .
When the present evidence, that collagen may be formed by macrophages in experimental pathologic circumstances, is confirmed by other investigators, this new information will carry considerable theoretical and practical significance. Long-standing questions about the formation of granulomas (Narayanan et al., 1982) , about fibrosis in certain forms of cancer such as mammary carcinoma with productive fibrosis (scirrhous) (Azzopardi, 1979) , and about the pathology of connective tissue diseases with suspected immunopathologic etiology such as rheumatoid arthritis (Christian, 1971) , pulmonary fibrosis (Kravis et al., 1976) , and progressive systemic sclerosis (Rodman, 1971) , could become better understood.
